IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported a second-quarter loss of $121.9 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Irvine, California-based company said it had a loss of 20 cents. Earnings, adjusted for one-time gains and costs, were 34 cents per share.
The results topped Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of 15 cents per share.
The medical device maker posted revenue of $925 million in the period, also topping Street forecasts. Nine analysts surveyed by Zacks expected $782.9 million.
For the current quarter ending in October, Edwards Lifesciences said it expects revenue in the range of $1 billion to $1.2 billion.
The company expects full-year earnings in the range of $1.75 to $1.95 per share, with revenue ranging from $4 billion to $4.5 billion.
Edwards Lifesciences shares have declined nearly 1% since the beginning of the year, while the Standard & Poor's 500 index has stayed nearly flat. In the final minutes of trading on Thursday, shares hit $77.32, a climb of 19% in the last 12 months.